Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIOP | ||||
| Company | Fortress Biotech Inc 9.375% Series A Cumulativ | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 16.43 | ||||
| High | 16.70 | ||||
| Low | 16.06 | ||||
| Latest | 16.70 | ||||
| Change | +0.40 | ||||
| % Change | +2.45% | ||||
| Volume | 14,200 | ||||
| 20-Day Average Volume | 19,720 | ||||
| Previous Close | 16.30 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 14.63 | ||||
| 20-Day Raw Stochastic | 100.00% | ||||
| 20-Day Relative Strength | 74.06 | ||||
| Weighted Alpha | +147.35 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 80% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.26% since 05/15/26 | ||||
| Low | 14.83 on 05/18/26 | ||||
| High | 16.70 on 05/22/26 | ||||
| 1-Month | |||||
| %Chg | +24.35% since 04/22/26 | ||||
| Low | 13.25 on 05/13/26 | ||||
| High | 16.70 on 05/22/26 | ||||
| 3-Month | |||||
| %Chg | +51.82% since 02/20/26 | ||||
| Low | 12.30 on 02/23/26 | ||||
| High | 16.70 on 05/22/26 | ||||
| 6-Month | |||||
| %Chg | +155.74% since 11/21/25 | ||||
| Low | 6.50 on 11/24/25 | ||||
| High | 16.70 on 05/22/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 63,262,000 | ||||
| Annual Net Income | 6,815,000 | ||||
| Last Quarter Sales | 16,038,000 | ||||
| Last Quarter Net Income | 110,373,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||